162 related articles for article (PubMed ID: 18297689)
1. Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer.
Sugasawa H; Ichikura T; Tsujimoto H; Kinoshita M; Morita D; Ono S; Chochi K; Tsuda H; Seki S; Mochizuki H
J Surg Oncol; 2008 Apr; 97(5):445-50. PubMed ID: 18297689
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
[TBL] [Abstract][Full Text] [Related]
3. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
4. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of CXCL12 expression in gastric cancer.
Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T
Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CCR7 expression in gastric cancer.
Ishigami S; Natsugoe S; Nakajo A; Tokuda K; Uenosono Y; Arigami T; Matsumoto M; Okumura H; Hokita S; Aikou T
Hepatogastroenterology; 2007 Jun; 54(76):1025-8. PubMed ID: 17629031
[TBL] [Abstract][Full Text] [Related]
9. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema.
Kato Y; Pawankar R; Kimura Y; Kawana S
Int Arch Allergy Immunol; 2006; 139(3):245-57. PubMed ID: 16449815
[TBL] [Abstract][Full Text] [Related]
11. Correlation between expression levels of thymidine phosphorylase (dThdPase) and clinical features in human gastric carcinoma.
Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
Hepatogastroenterology; 2002; 49(45):882-6. PubMed ID: 12064013
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
Dai N; Bao Q; Lu A; Li J
Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor size in T3 gastric cancer.
Liu X; Xu Y; Long Z; Zhu H; Wang Y
Ann Surg Oncol; 2009 Jul; 16(7):1875-82. PubMed ID: 19373514
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Jin DK; Kim S
J Surg Res; 2007 Dec; 143(2):344-9. PubMed ID: 17688884
[TBL] [Abstract][Full Text] [Related]
15. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.
Vande Broek I; Leleu X; Schots R; Facon T; Vanderkerken K; Van Camp B; Van Riet I
Haematologica; 2006 Feb; 91(2):200-6. PubMed ID: 16461304
[TBL] [Abstract][Full Text] [Related]
17. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
[TBL] [Abstract][Full Text] [Related]
18. Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3.
Elsner J; Dulkys Y; Gupta S; Escher SE; Forssmann WG; Kapp A; Forssmann U
Allergy; 2005 Nov; 60(11):1386-93. PubMed ID: 16197470
[TBL] [Abstract][Full Text] [Related]
19. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
20. Effects of thymidine phosphorylase levels in cancer, background mucosa, and regional lymph nodes on survival of advanced gastric cancer patients receiving postoperative fluoropyrimidine therapy.
Kosaka T; Usami K; Ueshige N; Sugaya J; Nakano Y; Takashima S
Oncol Rep; 2004 Dec; 12(6):1279-86. PubMed ID: 15547751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
